Yangzhou, China Clinical Trials

A listing of Yangzhou, China clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17 clinical trials
A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection

The purpose of this study is to evaluate the efficacy of helicobacter pylori (HP) eradication with bismuth-containing quadruple therapy with vonoprazan versus esomeprazole in all HP-positive participants.

amoxicillin
omeprazole
bismuth
clarithromycin
helicobacter pylori infection
Yangzhou First People's Hospital
 (0.0 away) Contact site
  • 0 views
  • 13 Sep, 2020
  • +28 other locations
Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).

This is a randomized, open-label, multi-center, global, Phase III study to determine the efficacy and safety of durvalumab + tremelimumab combination therapy + Standard of care (SoC) chemotherapy or durvalumab monotherapy + SoC chemotherapy versus SoC chemotherapy alone as first line treatment in patients with metastatic non small-cell lung cancer …

Research Site
 (2.0 away) Contact site
  • 712 views
  • 05 Nov, 2020
  • +143 other locations
A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients

This is a Phase III, randomised, double-blind, placebo-controlled, multicentre study assessing the efficacy and safety of durvalumab compared with placebo, as consolidation therapy in patients with locally advanced, unresectable, non-small cell lung cancer (Stage III), who have not progressed following definitive, platinum-based, chemoradiation therapy.

lung carcinoma
chemoradiotherapy
durvalumab
Research Site
 (2.0 away) Contact site
  • 284 views
  • 25 Nov, 2020
  • +144 other locations
Vitamin C Thiamine and Hydrocortisone for the Treatment of Septic Shock

The purpose of this study is to determine whether the combination therapy (vitamin C,thiamine and hydrocortisone) is effective in the treatment of septic shock.

thiamine
Northern Jiangsu Province people's hospital
 (0.0 away) Contact site
  • 0 views
  • 26 Oct, 2020
  • 1 location
Study of Tislelizumab (BGB-A317) Versus Placebo in Combination With Chemoradiotherapy in Patient With ESCC

This is a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare the efficacy and safety of BGB-A317 versus Placebo with chemoradiotherapy in Patients with Localized Esophageal Squamous Cell Carcinoma.

Northern Jiangsu people's hospital
 (2.0 away) Contact site
  • 1 views
  • 10 Nov, 2019
  • +5 other locations
R CEOP90 Versus R CEOP75 in Newly Diagnosed Young Patients With Medium/High-risk DLBCL

This clinical trial is designed to compare the efficacy and safety of RCEOP90 containing high-dose epirubicin and RCEOP75 containing standard epirubicin in newly diagnosed young patients with medium/high-risk diffuse large B-cell lymphoma. Half of the participants receive RCEOP regimen containing 90mg/m2 epirubicin, while the other half of participants receive RCEOP …

platelet count
b-cell lymphoma
rituximab
Northern Jiangsu People's Hospital
 (2.0 away) Contact site
  • 38 views
  • 08 Nov, 2020
  • +5 other locations
Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II

The primary objective of this trial is to assess the effects of ticagrelor plus aspirin versus clopidogrel plus aspirin on reducing the 3-month risk of any stroke (both ischemic and hemorrhagic, primary outcome) when initiated within 24 hours of symptom onset in CYP2Y19 LOF alleles carriers with TIA or minor …

clopidogrel
stroke
ticagrelor
aspirin
cerebral infarction
Affiliated Hospital of Yangzhou University
 (0.4 away) Contact site
  • 0 views
  • 30 Jul, 2020
  • +205 other locations
Study of Durvalumab + Tremelimumab Durvalumab and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as Consolidation Treatment for Patients with LS-SCLC Who Have Not Progressed Following Concurrent Chemoradiation Therapy

prophylactic cranial irradiation
cancer chemotherapy
etoposide
chemoradiotherapy
limited stage small cell lung cancer
Research Site
 (2.0 away) Contact site
  • 268 views
  • 26 Nov, 2020
  • +217 other locations
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)

This is a randomised, double-blind, parallel group, placebo-controlled study designed to evaluate the efficacy and safety of a fixed 30 mg dose of benralizumab administered subcutaneously for patients with a history of asthma exacerbations and uncontrolled asthma receiving medium to high-dose inhaled corticosteroid plus long-acting 2-agonist (ICS-LABA) with or without …

benralizumab
leukotriene receptor antagonist
theophylline
corticosteroids
bronchodilator
Research Site
 (2.0 away) Contact site
  • 696 views
  • 22 Nov, 2020
  • +55 other locations
A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

The purpose of this study is to evaluate the efficacy and safety of Tislelizumab as first line treatment in combination with chemotherapy in participants with advanced unresectable/metastatic ESCC.

paclitaxel
carcinoma
capecitabine
fluorouracil
squamous cell carcinoma
Subei People's Hospital
 (2.0 away) Contact site
  • 24 views
  • 23 Sep, 2020
  • +204 other locations